Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$440,000 |
 |
Johnson & JohnsonJNJ |
-$120M |
 |
ModernaMRNA |
-$37.4B |
 |
AbbVieABBV |
-$792M |
 |
Eli Lilly and CompanyLLY |
-$334,465B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Karlin Daniel | Dec 26, 2025 | Sell | 5,600 | $13.1469 | $74,000 |
| Barrow Robert | Dec 26, 2025 | Sell | 25,791 | $13.1469 | $340,000 |
| Sullivan Mark | Dec 26, 2025 | Sell | 11,276 | $13.1469 | $150,000 |
| Sullivan Mark | Sep 25, 2025 | Sell | 11,278 | $9.77 | $110,000 |
| Barrow Robert | Sep 25, 2025 | Sell | 25,797 | $9.77 | $250,000 |
| Karlin Daniel | Sep 25, 2025 | Sell | 7,704 | $9.77 | $75,000 |
| Barrow Robert | Jun 25, 2025 | Sell | 26,491 | $6.8 | $180,000 |
| Sullivan Mark | Jun 25, 2025 | Sell | 11,491 | $6.8 | $78,000 |
| Karlin Daniel | Jun 25, 2025 | Sell | 7,848 | $6.8 | $53,000 |
| Liao Carrie | Mar 25, 2025 | Sell | 2,347 | $6.74 | $16,000 |
| Sullivan Mark | Mar 25, 2025 | Sell | 6,576 | $6.74 | $44,000 |
| Barrow Robert | Mar 25, 2025 | Sell | 21,208 | $6.74 | $140,000 |
| Karlin Daniel | Mar 25, 2025 | Sell | 6,836 | $6.74 | $46,000 |
| Sullivan Mark | Dec 26, 2024 | Sell | 4,519 | $7.43 | $34,000 |
| Karlin Dan | Dec 26, 2024 | Sell | 6,643 | $7.43 | $49,000 |
| Liao Carrie | Dec 26, 2024 | Sell | 2,273 | $7.43 | $17,000 |
| Barrow Robert | Dec 26, 2024 | Sell | 19,106 | $7.43 | $140,000 |
| GRYSKA DAVID W | Dec 5, 2024 | Buy | 2,500 | $7.17 | $18,000 |
| Sullivan Mark | Sep 25, 2024 | Sell | 4,430 | $5.98 | $26,000 |
| Barrow Robert | Sep 25, 2024 | Sell | 19,771 | $5.98 | $120,000 |
| Liao Carrie | Sep 25, 2024 | Sell | 2,352 | $5.98 | $14,000 |
| Karlin Dan | Sep 25, 2024 | Sell | 6,871 | $5.98 | $41,000 |
| GRYSKA DAVID W | Aug 23, 2024 | Buy | 3,500 | $5.98 | $21,000 |
| Barrow Robert | Aug 20, 2024 | Buy | 500 | $6.12 | $3,100 |
| Sullivan Mark | Jun 25, 2024 | Sell | 17,854 | $7.22 | $130,000 |
| Karlin Dan | Jun 25, 2024 | Sell | 6,925 | $7.22 | $50,000 |
| Barrow Robert | Jun 25, 2024 | Sell | 15,659 | $7.22 | $110,000 |
| Barrow Robert | Mar 25, 2024 | Sell | 16,519 | $9.5 | $160,000 |
| Karlin Dan | Mar 25, 2024 | Sell | 6,578 | $9.5 | $62,000 |
FAQ - Insider Transactions
The most recent insider transaction for Mind Medicine (MindMed) was conducted by Karlin Daniel, who sold 5,600 shares on December 26, 2025 at a price of $13.15 per share.
GRYSKA DAVID W has bought the most MNMD stock in the last 2 years, with a total value of $39,000.
Barrow Robert has sold the most MNMD stock in the last 2 years, with a total value of $1.4M.
The total value of insider transactions for Mind Medicine (MindMed) in the last 2 years is negative, amounting to -$2.5M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Mind Medicine (MindMed) have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
